Zoetis | ZTS - Interest Expense On Debt


Zoetis reported $62M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Align Technology USD 16.04M 14.04M Dec/2025
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Coherus Biosciences USD 2.25M 76K Dec/2025
Dentsply International USD 24M 2M Mar/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Henry Schein USD 39M 0 Mar/2026
Idexx Laboratories USD 7.74M 2.34M Mar/2026
Illumina USD 26M 1000K Dec/2025
IQVIA Holdings USD 192M 1000K Mar/2026
J&J USD 43M 25M Mar/2026
Laboratory Of America USD 55.1M 100K Mar/2026
Merck USD 479M 67M Mar/2026
Neogen USD 13.9M 356K Dec/2025
Pacira USD 3.7M 193K Mar/2026
Perrigo USD 7.98B 7.94B Mar/2026
Pfizer USD 671M 40M Mar/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Sanofi EUR 178M 203M Mar/2026
Sanofi EUR -25M 99.78M Dec/2025
Zoetis USD 62M 5M Mar/2026